ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
관절 내 관절액 보충요법 시장 규모는 최근 급성장하고 있습니다. 2025년 45억 달러에서 2026년에는 49억 7,000만 달러에 이르고, CAGR 10.4%의 성장이 전망되고 있습니다. 지난 수년간의 성장세는 골관절염 유병률 증가, 고령 인구 증가, 관절 치료 기술의 발전, 관절내치환술에 대한 인식 개선, 정형외과 의료 인프라 확충 등이 주요 요인으로 꼽힙니다.
관절 내 관절액 보충요법 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 73억 4,000만 달러에 이르고, CAGR은 10.2%를 나타낼 전망입니다. 예측 기간 동안의 성장 요인으로는 재생의료 도입, 디지털 건강 모니터링의 통합, 새로운 히알루론산 제제 개발, 외래수술센터(ASC)의 확장, 외래 정형외과 수술에 대한 투자 증가 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 최소침습적 관절 치료, 재생의료의 통합, 맞춤형 골관절염 치료, 주사용 히알루론산 혁신, 외래 정형외과 수술 등이 있습니다.
골관절염의 유병률 증가는 향후 몇 년 동안 관절내장치료제 시장의 성장을 견인할 것으로 예측됩니다. 골관절염은 관절, 특히 고관절, 무릎관절, 손관절이 퇴행성 관절염의 일종인 퇴행성 관절질환으로 관절이 악화되기 시작하면서 발병하는 퇴행성 관절염의 일종입니다. 관절내 보충요법은 히알루론산을 관절 내에 직접 주입하여 통증을 완화하고 원활한 뼈의 움직임을 촉진하여 통증 완화 및 관절 기능 개선에 기여합니다. 예를 들어, 2023년 8월 미국의 비영리 세계보건연구기관인 건강지표평가연구소(IHME)가 발표한 보고서에 따르면 2050년까지 무릎 골관절염은 75%, 손 골관절염은 50% 증가할 것으로 예측했습니다. 따라서 골관절염 증가 추세가 관절내치환술 시장의 성장을 견인하고 있는 것입니다.
관절내 치환술 시장의 주요 기업들은 흡수성 히알루론산 스카라폴드와 같은 혁신적인 제품 개발에 주력하고 있습니다. 이는 관절의 윤활을 개선하고, 조직 재생을 촉진하며, 골관절염 증상으로부터 장기적인 완화를 제공하여 환자의 치료 결과를 개선하고 치료 옵션을 확대합니다. 흡수성 히알루론산 스카라폴드는 결합조직에 자연적으로 존재하는 다당류인 히알루론산(HA)으로 만든 생체적합성, 생분해성 구조물입니다. 예를 들어, 2023년 5월, 미국에 본사를 둔 정형외과 전문 기업 애니카 테라퓨틱스(Anika Therapeutics)는 연골 수복용 단일 단계형 기성품 흡수성 히알루론산 스캐폴드 'Hyalofast'를 출시하였습니다. Hyalofast는 관절 보존을 위한 히알루론산 기반 솔루션을 제공하여 보다 침습적인 수술의 대안이 될 수 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Viscosupplementation is a process in which hyaluronic acid, a gel-like fluid, is injected directly into a joint. Synovial fluid, naturally present around joints, contains hyaluronic acid, which helps reduce friction during movement.
The primary types of viscosupplementation include single-injection, three-injection, and five-injection viscosupplementation. Single-injection viscosupplementation involves a single shot of hyaluronic acid injected directly into the diarthrodial joints of a person's knees, aimed at restoring the rheological properties of the synovial fluid, thereby providing anti-inflammatory and analgesic effects. Hyaluronic acid, including both standard and stabilized forms, can be derived from avian and non-avian sources. These treatments are used to manage various osteoarthritides, including knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis, and are administered in settings such as hospitals, ambulatory surgical centers, and others.
Tariffs have impacted the viscosupplementation market by increasing the cost of imported hyaluronic acid and related injectable components, leading to higher production and treatment costs. This disruption particularly affects single, three, and five injection types and regions heavily reliant on imports, such as North America and Europe. Hospitals and ambulatory surgical centers face cost pressures, while local manufacturing initiatives may see growth. Overall, tariffs are driving manufacturers to explore domestic sourcing and cost-efficient innovations.
The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation market statistics, including viscosupplementation industry global market size, regional shares, competitors with a viscosupplementation market share, detailed viscosupplementation market segments, market trends and opportunities, and any further data you may need to thrive in the viscosupplementation industry. This viscosupplementation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The viscosupplementation market size has grown rapidly in recent years. It will grow from $4.5 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising prevalence of osteoarthritis, increasing geriatric population, advancements in joint care therapies, growing awareness of viscosupplementation, expanding orthopedic healthcare infrastructure.
The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $7.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to adoption of regenerative medicine, integration of digital health monitoring, development of novel hyaluronic acid formulations, expansion of ambulatory surgical centers, rising investments in outpatient orthopedic procedures. Major trends in the forecast period include minimally invasive joint therapies, regenerative medicine integration, personalized osteoarthritis treatment, injectable hyaluronic acid innovations, outpatient orthopedic procedures.
The growing prevalence of osteoarthritis is expected to drive the expansion of the viscosupplementation market in the coming years. Osteoarthritis, a degenerative joint disease and a common form of arthritis, occurs when the joints, particularly in the hips, knees, and hands, begin to deteriorate. Viscosupplementation treatments help alleviate pain and facilitate smooth bone movement by injecting hyaluronic acid directly into the joints, reducing pain and improving joint functionality. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a U.S.-based nonprofit global health research center, reported that by 2050, osteoarthritis of the knee is expected to increase by 75%, and osteoarthritis of the hand by 50%. Therefore, the rising prevalence of osteoarthritis is driving the growth of the viscosupplementation market.
Leading companies in the viscosupplementation market are focusing on developing innovative products, such as resorbable hyaluronic acid scaffolds, to improve joint lubrication, promote tissue regeneration, and offer long-lasting relief from osteoarthritis symptoms, thereby enhancing patient outcomes and broadening treatment options. A resorbable hyaluronic acid scaffold is a biocompatible, biodegradable structure made from hyaluronic acid (HA), a naturally occurring polysaccharide in connective tissues. For instance, in May 2023, Anika Therapeutics, Inc., a U.S.-based company specializing in orthopedics, launched Hyalofast, a single-stage, off-the-shelf, resorbable hyaluronic acid scaffold for cartilage repair. Hyalofast provides a hyaluronic acid-based solution for joint preservation, potentially offering an alternative to more invasive surgical procedures.
In August 2025, Ono Pharmaceutical Co., Ltd., a Japan-based provider of pharmaceuticals and medical products, partnered with Seikagaku Corporation to co-develop and market Gel-One, a hyaluronic acid-based viscosupplement for osteoarthritis. Through this partnership, the companies aim to expand their presence in the Japanese viscosupplementation market by combining Seikagaku's product development and manufacturing expertise with Ono's marketing and distribution network. Seikagaku Corporation is a Japan-based developer and manufacturer of hyaluronic acid therapeutics, including injectable viscosupplements for joint health.
Major companies operating in the viscosupplementation market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.
North America was the largest region in the viscosupplementation market in 2025. The regions covered in the viscosupplementation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Viscosupplementation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses viscosupplementation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for viscosupplementation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viscosupplementation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Type: Single Injection Viscosupplementation; Three Injection Viscosupplementation; Five Injection Viscosupplementation
2) By Source: Avian Origin; Non-Avian Origin
3) By Hyaluronic Acids: Standard Hyaluronic Acid; Stabilized Hyaluronic Acid
4) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis
5) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products; Non-Hyaluronic Acid Products
2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Minimally Invasive Joint Therapies
4.2.2 Regenerative Medicine Integration
4.2.3 Personalized Osteoarthritis Treatment
4.2.4 Injectable Hyaluronic Acid Innovations
4.2.5 Outpatient Orthopedic Procedures
5. Viscosupplementation Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Ambulatory Surgical Centers
5.3 Orthopedic Clinics
5.4 Rehabilitation Centers
5.5 Sports Medicine Centers
6. Viscosupplementation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Viscosupplementation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Viscosupplementation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Viscosupplementation Market Size, Comparisons And Growth Rate Analysis
7.3. Global Viscosupplementation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Viscosupplementation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Viscosupplementation Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Viscosupplementation Market Segmentation
9.1. Global Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
9.2. Global Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Avian Origin, Non-Avian Origin
9.3. Global Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
9.4. Global Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
9.5. Global Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Ambulatory Surgical Centers, Other End-Users
9.6. Global Viscosupplementation Market, Sub-Segmentation Of Single Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Viscosupplementation Market, Sub-Segmentation Of Three Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.8. Global Viscosupplementation Market, Sub-Segmentation Of Five Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Viscosupplementation Market
12.1. China Viscosupplementation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Viscosupplementation Market
13.1. India Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Viscosupplementation Market
14.1. Japan Viscosupplementation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Viscosupplementation Market
15.1. Australia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Viscosupplementation Market
16.1. Indonesia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Viscosupplementation Market
17.1. South Korea Viscosupplementation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Viscosupplementation Market
18.1. Taiwan Viscosupplementation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Viscosupplementation Market
19.1. South East Asia Viscosupplementation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Viscosupplementation Market
20.1. Western Europe Viscosupplementation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Viscosupplementation Market
21.1. UK Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Viscosupplementation Market
22.1. Germany Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Viscosupplementation Market
23.1. France Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Viscosupplementation Market
24.1. Italy Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Viscosupplementation Market
25.1. Spain Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Viscosupplementation Market
26.1. Eastern Europe Viscosupplementation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Viscosupplementation Market
27.1. Russia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Viscosupplementation Market
28.1. North America Viscosupplementation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Viscosupplementation Market
29.1. USA Viscosupplementation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Viscosupplementation Market
30.1. Canada Viscosupplementation Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Viscosupplementation Market
31.1. South America Viscosupplementation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Viscosupplementation Market
32.1. Brazil Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Viscosupplementation Market
33.1. Middle East Viscosupplementation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Viscosupplementation Market
34.1. Africa Viscosupplementation Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Viscosupplementation Market Regulatory and Investment Landscape
36. Viscosupplementation Market Competitive Landscape And Company Profiles
36.1. Viscosupplementation Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Viscosupplementation Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Viscosupplementation Market Company Profiles
36.3.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
36.3.2. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Bioventus LLC Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
37. Viscosupplementation Market Other Major And Innovative Companies
